BR0100954A - Utilização de o-vanilina e combinações deo-vanilina/trolox(r) - Google Patents
Utilização de o-vanilina e combinações deo-vanilina/trolox(r)Info
- Publication number
- BR0100954A BR0100954A BR0100954-0A BR0100954A BR0100954A BR 0100954 A BR0100954 A BR 0100954A BR 0100954 A BR0100954 A BR 0100954A BR 0100954 A BR0100954 A BR 0100954A
- Authority
- BR
- Brazil
- Prior art keywords
- methoxysalicylaldehyde
- derivative
- radiation
- vanillin
- protein
- Prior art date
Links
- JJVNINGBHGBWJH-UHFFFAOYSA-N ortho-vanillin Chemical compound COC1=CC=CC(C=O)=C1O JJVNINGBHGBWJH-UHFFFAOYSA-N 0.000 title abstract 15
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 title abstract 2
- ONAOBFWXMNPKEQ-UHFFFAOYSA-N 2-methylperoxybenzaldehyde Chemical class COOC1=CC=CC=C1C=O ONAOBFWXMNPKEQ-UHFFFAOYSA-N 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 230000005855 radiation Effects 0.000 abstract 4
- RLNWRDKVJSXXPP-UHFFFAOYSA-N tert-butyl 2-[(2-bromoanilino)methyl]piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1CNC1=CC=CC=C1Br RLNWRDKVJSXXPP-UHFFFAOYSA-N 0.000 abstract 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- 230000005865 ionizing radiation Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001012 protector Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Patente de Invenção: "UTILIZAçãO DE o-VANILINA ECOMBINAçõES DE O-VANILINA/TROLOX<32>". A invençãoproporciona métodos de proteção a proteínas no estado sólidocontra os efeitos da radiação ionizante, os quais compreendem acombinação da proteína com uma quantidade protetora daradiação de um derivado de metoxissalicilaldeído, de preferência o3-metoxissalicilaldeído; ou uma quantidade protetora da radiaçãode um derivado de metoxissalicilaldeído, de preferência o3-metoxissalicilaldeído e o ácido6-hidróxi-2,5,7,8-tetrametilcroman-2-carboxílico; ou uma quantidadeprotetora da radiação de um derivado de metoxissalicilaldeído, depreferência o 3-metoxissalicilaldeído e o isopropanol, antes daexposição da proteína à radiação ionizante. A invenção aindaproporciona formulações farmacêuticas resistentes à radiação,compreendendo uma proteína e um derivado de ummetoxissalicilaldeído, de preferência o 3-metoxissalicilaldeído; umaproteína e uma combinação de um derivado de ummetoxissalicilaldeído, de preferência o 3-metoxissalicilaldeído e oácido 6-hidróxi-2,5,7,8-tetrametilcroman-2carboxílico; ou umaproteína e uma combinação de um derivado de ummetoxissalicilaldeído, de preferência o 3-metoxissalicilaldeído eisopropanol. Esta invenção ainda proporciona composiçõescompreendendo uma combinação de um derivado de ummetoxissalicilaldeído, de preferência o 3-metoxissalicilaldeído e oácido 6-hidróxi-2,5,7,8-tetrametilcroman-2-carboxílico e a utilizaçãode tais composições em formulações farmacêuticas comoprotetoras de radiações.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18910100P | 2000-03-14 | 2000-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0100954A true BR0100954A (pt) | 2001-12-18 |
Family
ID=22695930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0100954-0A BR0100954A (pt) | 2000-03-14 | 2001-03-13 | Utilização de o-vanilina e combinações deo-vanilina/trolox(r) |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6764993B2 (pt) |
| EP (1) | EP1136080A3 (pt) |
| JP (1) | JP2001316294A (pt) |
| BR (1) | BR0100954A (pt) |
| CA (1) | CA2340549A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070160675A1 (en) * | 1998-11-02 | 2007-07-12 | Elan Corporation, Plc | Nanoparticulate and controlled release compositions comprising a cephalosporin |
| MXPA01004381A (es) | 1998-11-02 | 2005-09-08 | Elan Corp Plc | Composicion de multiparticulado de liberacion modificada. |
| EP1400248A1 (en) * | 2002-09-19 | 2004-03-24 | Aventis Behring GmbH | Process for sterilization of protein containing biological compositions |
| EP1415669A1 (en) * | 2002-09-19 | 2004-05-06 | Aventis Behring GmbH | Process for sterilization of protein containing biological compositions |
| EP1626742A1 (en) | 2003-05-22 | 2006-02-22 | Elan Pharma International Limited | Sterilization of dispersions of nanoparticulate active agents with gamma radiation |
| US8349359B2 (en) | 2004-11-07 | 2013-01-08 | Your Energy Systems, LLC | Liposomal formulation for oral administration of glutathione (reduced) |
| US20090155331A1 (en) * | 2005-11-16 | 2009-06-18 | Elan Pharma International Limited | Injectable nanoparticulate olanzapine formulations |
| CN101106972A (zh) * | 2004-11-16 | 2008-01-16 | 伊兰制药国际有限公司 | 注射用纳米微粒奥氮平制剂 |
| MX2009013332A (es) | 2007-06-08 | 2010-01-25 | Mannkind Corp | Inhibidores de ire-1 alfa. |
| US20090238867A1 (en) * | 2007-12-13 | 2009-09-24 | Scott Jenkins | Nanoparticulate Anidulafungin Compositions and Methods for Making the Same |
| US20090311335A1 (en) * | 2008-06-12 | 2009-12-17 | Scott Jenkins | Combination of a triptan and an nsaid |
| EP3280256A4 (en) * | 2015-04-06 | 2018-12-12 | University of Maryland, Baltimore | Small molecule inhibitors of tlr2 signaling |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3986980A (en) | 1974-04-29 | 1976-10-19 | Hoffmann-La Roche Inc. | Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid |
| US5490991A (en) * | 1986-07-03 | 1996-02-13 | Advanced Magnetics, Inc. | Directed delivery of radioprotectants using a receptor specific carrier |
| US4714609A (en) * | 1986-07-21 | 1987-12-22 | Laverne Stanley | Skin tanning composition |
| CA1296253C (en) * | 1986-10-20 | 1992-02-25 | Praveen Tyle | Stabilized growth hormone compositions |
| US5015627A (en) | 1990-07-20 | 1991-05-14 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
| WO1993010755A1 (en) * | 1991-11-25 | 1993-06-10 | Richardson-Vicks, Inc. | Compositions for regulating skin wrinkles and/or skin atrophy |
| US5198422A (en) * | 1992-06-11 | 1993-03-30 | Smithkline Beecham Corporation | Stabilized somatotropin for parenteral administration |
| US5811083A (en) * | 1996-03-26 | 1998-09-22 | Estee Lauder, Inc. | Tocopherol derivatives for use in cosmetic compositions |
| US5730933A (en) * | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
| US5840734A (en) * | 1997-05-06 | 1998-11-24 | Thomas Jefferson University | Use of tempol in the prevention of photoaging |
| CA2331388A1 (en) * | 1998-06-26 | 2000-01-06 | Michael Thomas Clark | Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |
-
2001
- 2001-03-07 EP EP01302066A patent/EP1136080A3/en not_active Withdrawn
- 2001-03-07 JP JP2001062892A patent/JP2001316294A/ja not_active Withdrawn
- 2001-03-12 US US09/805,016 patent/US6764993B2/en not_active Expired - Fee Related
- 2001-03-12 CA CA002340549A patent/CA2340549A1/en not_active Abandoned
- 2001-03-13 BR BR0100954-0A patent/BR0100954A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20010049354A1 (en) | 2001-12-06 |
| EP1136080A3 (en) | 2002-06-05 |
| US6764993B2 (en) | 2004-07-20 |
| CA2340549A1 (en) | 2001-09-14 |
| JP2001316294A (ja) | 2001-11-13 |
| EP1136080A2 (en) | 2001-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1117440E (pt) | Composicoes farmaceuticas que contem paclitaxel | |
| BR0314356A (pt) | Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas | |
| BR0100954A (pt) | Utilização de o-vanilina e combinações deo-vanilina/trolox(r) | |
| TR200001218T2 (tr) | İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler. | |
| BR0111222A (pt) | Derivados fosfonados de glicopeptìdeo | |
| EA200401471A1 (ru) | Применение ингибиторов сетр и возможных ингибиторов hmg coa и/или антигипертензивных агентов | |
| GT199700089A (es) | Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido. | |
| AR020345A1 (es) | Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones. | |
| GT199700095A (es) | Derivados 6,5-heterobiciclicos sustituidos. | |
| BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| MX9709874A (es) | N-(INDOL-2-CARBONIL) beta-ALANILAMIDAS SUSTITUIDAS Y DERIVADOS COMO INHIBIDORES DE GLUCOGENO FOSFORILASA, USO DE LOS MISMOS Y COMPOSICIONES QUE LOS CONTIENEN. | |
| NO944643D0 (no) | Protein-kinase-C-hemmere | |
| BR0107147A (pt) | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações | |
| BR9814698A (pt) | Combinação de um inibidor da aldose-redutase com um inibidor do glicogênio-fosforilase | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| BR0211187A (pt) | Composição que contém um peptìdeo e um pigmento e o uso da mesma no escurecimento da pele | |
| CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
| AP2000001947A0 (en) | Novel crystalline forms of an antiviral benzidazole compound. | |
| ATE231872T1 (de) | Thiazolopyrimidinderivate | |
| ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
| PT1246809E (pt) | Compostos de 5-aril-1h-1,2,4-triazole como inibidores de ciclooxigenase-2 e composicoes farmaceuticas que os contem | |
| BRPI0411830A (pt) | método de proteção de compostos bio-ativos e composições contendo os mesmos | |
| BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
| ID18079A (id) | Komposisi farmasi yang mengandung bahan pemercepat osteogenesis | |
| BR0010553A (pt) | Derivados de furanona como inibidores de catepsina s |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009. |